Curtis R. Ginder MD, MBA , Jacob C. Jentzer MD, MSc , Siddharth M. Patel MD, MPH , Erin A. Bohula MD, DPhil , Carlos E. Alfonso MD , Christopher F. Barnett MD, MPH , Gregory W. Barsness MD , Mark W. Dodson MD, PhD , Shahab Ghafghazi MD, MRCP , Umesh Gidwani MD, MS , Jianping Guo MAS , Younghoon Kwon MD , Shuangbo Liu MD , Venu Menon MD , Sarah A. Morrow , Connor G. O’Brien MD , Brian J. Potter MDCM, SM , Jason N. Katz MD, MHS , Sean van Diepen MD, MSc , David D. Berg MD, MPH
{"title":"心源性休克患者压力调整心率与住院死亡率的关系","authors":"Curtis R. Ginder MD, MBA , Jacob C. Jentzer MD, MSc , Siddharth M. Patel MD, MPH , Erin A. Bohula MD, DPhil , Carlos E. Alfonso MD , Christopher F. Barnett MD, MPH , Gregory W. Barsness MD , Mark W. Dodson MD, PhD , Shahab Ghafghazi MD, MRCP , Umesh Gidwani MD, MS , Jianping Guo MAS , Younghoon Kwon MD , Shuangbo Liu MD , Venu Menon MD , Sarah A. Morrow , Connor G. O’Brien MD , Brian J. Potter MDCM, SM , Jason N. Katz MD, MHS , Sean van Diepen MD, MSc , David D. Berg MD, MPH","doi":"10.1016/j.jacadv.2025.102065","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Among patients with cardiogenic shock (CS), higher right atrial pressure (RAP) and lower mean arterial pressure (MAP) are associated with higher in-hospital mortality. Pressure-adjusted heart rate (PAHR), defined as heart rate × RAP/MAP, integrates these parameters. The prognostic significance of PAHR has not been assessed in patients with CS.</div></div><div><h3>Objectives</h3><div>The authors aimed to assess if PAHR values are associated with risk of in-hospital mortality in patients with CS.</div></div><div><h3>Methods</h3><div>CCCTN (Critical Care Cardiology Trials Network) is a multinational registry of cardiac intensive care units coordinated by the TIMI Study Group. Among CS admissions (2018-2023) undergoing invasive hemodynamic assessment within 24 hours of cardiac intensive care unit admission, we assessed the relationship of PAHR with in-hospital mortality. Patients with concurrent mechanical circulatory support were excluded in the primary analysis. ORs were adjusted for age, sex, vasoactive-inotropic score, Society for Cardiovascular Angiography and Interventions (SCAI) stage, and preceding cardiac arrest.</div></div><div><h3>Results</h3><div>Among the 1411 CS admissions in the analysis (18% with acute myocardial infarction), 75% were receiving vasoactive support at the time of assessment. Median heart rate was 92 beats/min, RAP 15 mm Hg, MAP 75 mm Hg, and PAHR 17. There was a stepwise gradient of higher in-hospital mortality with higher presenting PAHR values. In adjusted models, a higher PAHR was incrementally associated with higher in-hospital mortality (adjusted OR per 10 units: 1.35 [95% CI: 1.15-1.58]), and PAHR had stronger prognostic associations with mortality than its individual hemodynamic components.</div></div><div><h3>Conclusions</h3><div>PAHR, a simple hemodynamic index calculated from vital signs and central venous pressure, is strongly associated with in-hospital mortality in CS.</div></div>","PeriodicalId":73527,"journal":{"name":"JACC advances","volume":"4 10","pages":"Article 102065"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association Between Pressure-Adjusted Heart Rate and In-Hospital Mortality in Cardiogenic Shock\",\"authors\":\"Curtis R. Ginder MD, MBA , Jacob C. Jentzer MD, MSc , Siddharth M. Patel MD, MPH , Erin A. Bohula MD, DPhil , Carlos E. Alfonso MD , Christopher F. Barnett MD, MPH , Gregory W. Barsness MD , Mark W. Dodson MD, PhD , Shahab Ghafghazi MD, MRCP , Umesh Gidwani MD, MS , Jianping Guo MAS , Younghoon Kwon MD , Shuangbo Liu MD , Venu Menon MD , Sarah A. Morrow , Connor G. O’Brien MD , Brian J. Potter MDCM, SM , Jason N. Katz MD, MHS , Sean van Diepen MD, MSc , David D. Berg MD, MPH\",\"doi\":\"10.1016/j.jacadv.2025.102065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Among patients with cardiogenic shock (CS), higher right atrial pressure (RAP) and lower mean arterial pressure (MAP) are associated with higher in-hospital mortality. Pressure-adjusted heart rate (PAHR), defined as heart rate × RAP/MAP, integrates these parameters. The prognostic significance of PAHR has not been assessed in patients with CS.</div></div><div><h3>Objectives</h3><div>The authors aimed to assess if PAHR values are associated with risk of in-hospital mortality in patients with CS.</div></div><div><h3>Methods</h3><div>CCCTN (Critical Care Cardiology Trials Network) is a multinational registry of cardiac intensive care units coordinated by the TIMI Study Group. Among CS admissions (2018-2023) undergoing invasive hemodynamic assessment within 24 hours of cardiac intensive care unit admission, we assessed the relationship of PAHR with in-hospital mortality. Patients with concurrent mechanical circulatory support were excluded in the primary analysis. ORs were adjusted for age, sex, vasoactive-inotropic score, Society for Cardiovascular Angiography and Interventions (SCAI) stage, and preceding cardiac arrest.</div></div><div><h3>Results</h3><div>Among the 1411 CS admissions in the analysis (18% with acute myocardial infarction), 75% were receiving vasoactive support at the time of assessment. Median heart rate was 92 beats/min, RAP 15 mm Hg, MAP 75 mm Hg, and PAHR 17. There was a stepwise gradient of higher in-hospital mortality with higher presenting PAHR values. In adjusted models, a higher PAHR was incrementally associated with higher in-hospital mortality (adjusted OR per 10 units: 1.35 [95% CI: 1.15-1.58]), and PAHR had stronger prognostic associations with mortality than its individual hemodynamic components.</div></div><div><h3>Conclusions</h3><div>PAHR, a simple hemodynamic index calculated from vital signs and central venous pressure, is strongly associated with in-hospital mortality in CS.</div></div>\",\"PeriodicalId\":73527,\"journal\":{\"name\":\"JACC advances\",\"volume\":\"4 10\",\"pages\":\"Article 102065\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC advances\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772963X25004909\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC advances","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772963X25004909","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在心源性休克(CS)患者中,较高的右心房压(RAP)和较低的平均动脉压(MAP)与较高的住院死亡率相关。压力调节心率(PAHR),定义为心率× RAP/MAP,综合了这些参数。尚未评估PAHR在CS患者中的预后意义。目的作者旨在评估PAHR值是否与CS患者住院死亡风险相关。sccctn(重症监护心脏病学试验网络)是一个由TIMI研究组协调的跨国心脏重症监护病房注册。在心脏重症监护室入院24小时内接受有创血流动力学评估的CS患者(2018-2023)中,我们评估了PAHR与住院死亡率的关系。在初步分析中排除了同时使用机械循环支持的患者。ORs根据年龄、性别、血管活性性肌力评分、心血管血管造影与干预学会(SCAI)分期和之前的心脏骤停进行调整。结果在分析的1411例CS入院患者中(18%合并急性心肌梗死),75%在评估时接受血管活性支持。中位心率为92次/分,RAP为15 mm Hg, MAP为75 mm Hg, PAHR为17。PAHR值越高,住院死亡率越高。在调整后的模型中,较高的PAHR与较高的住院死亡率逐渐相关(每10单位调整的OR: 1.35 [95% CI: 1.15-1.58]), PAHR与死亡率的预后相关性强于其单独的血流动力学成分。结论spahr是由生命体征和中心静脉压计算的简单血流动力学指标,与CS住院死亡率密切相关。
Association Between Pressure-Adjusted Heart Rate and In-Hospital Mortality in Cardiogenic Shock
Background
Among patients with cardiogenic shock (CS), higher right atrial pressure (RAP) and lower mean arterial pressure (MAP) are associated with higher in-hospital mortality. Pressure-adjusted heart rate (PAHR), defined as heart rate × RAP/MAP, integrates these parameters. The prognostic significance of PAHR has not been assessed in patients with CS.
Objectives
The authors aimed to assess if PAHR values are associated with risk of in-hospital mortality in patients with CS.
Methods
CCCTN (Critical Care Cardiology Trials Network) is a multinational registry of cardiac intensive care units coordinated by the TIMI Study Group. Among CS admissions (2018-2023) undergoing invasive hemodynamic assessment within 24 hours of cardiac intensive care unit admission, we assessed the relationship of PAHR with in-hospital mortality. Patients with concurrent mechanical circulatory support were excluded in the primary analysis. ORs were adjusted for age, sex, vasoactive-inotropic score, Society for Cardiovascular Angiography and Interventions (SCAI) stage, and preceding cardiac arrest.
Results
Among the 1411 CS admissions in the analysis (18% with acute myocardial infarction), 75% were receiving vasoactive support at the time of assessment. Median heart rate was 92 beats/min, RAP 15 mm Hg, MAP 75 mm Hg, and PAHR 17. There was a stepwise gradient of higher in-hospital mortality with higher presenting PAHR values. In adjusted models, a higher PAHR was incrementally associated with higher in-hospital mortality (adjusted OR per 10 units: 1.35 [95% CI: 1.15-1.58]), and PAHR had stronger prognostic associations with mortality than its individual hemodynamic components.
Conclusions
PAHR, a simple hemodynamic index calculated from vital signs and central venous pressure, is strongly associated with in-hospital mortality in CS.